therapeutic 1,822 words KG: NAD+
Contents

NAD+ Precursors (NMN/NR) for Parkinson's Disease

💊 Therapeutic Info
NameNAD+
Key Genes/ProteinsAMPK, CD38, CX43
Related DiseasesAlzheimer disease, lifespan
Related Pathwayscellular senescence, epigenetic clocks, mitochondrial deacetylation
Linked Hypotheses23 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (36)

Proteostasis Enhancement via APOE Chaperone Targeting
Score: 0.72
HDAC3-Selective Inhibition for Clock Reset
Score: 0.71
Autophagosome Maturation Checkpoint Control
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.65
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.62
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m
Score: 0.62
SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.61
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci
Score: 0.60
Digital Twin-Guided Metabolic Reprogramming
Score: 0.55
Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.43
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Gap Junction Hemichannel Modulation for Controlled Mitochond
Score: 0.36
← Prevpg 2/2

Related Analyses (29)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · completed
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · completed
Epigenetic reprogramming in aging neurons
neurodegeneration · archived

Related Experiments (30)

NAD depletion effects on monocyte/macrophage differentiation
exploratory · proposed · Score: 0.90
Germfree mouse colonocyte energy metabolism analysis
validation · proposed · Score: 0.90
FK866 treatment in DSS-induced colitis mouse model
validation · proposed · Score: 0.90
FK866 in azoxymethane/DSS colitis-associated cancer model
validation · proposed · Score: 0.85
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?
clinical · proposed · Score: 0.40

See Also (5)

ATP P2X3 Receptor Neurons
cell · KG edge: causes
AMPK (AMP-Activated Protein Kinase)
entity · KG edge: activates
CD38 Molecule (CD38)
gene · KG edge: degrades
APP Gene Dosage Reduction Therapy for Down Syndrome
idea · KG edge: inhibits
Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: inhibits

Knowledge Graph (12 edges)

NAD+ activates SIRT1
AMPK contributes_to NAD+
NAD+ regulates SIRT1
NAD+ modulates SIRT1
CD38 depletes NAD+
PARP degrades NAD+
SIRT degrades NAD+
NAD+ protects_against BLOOD-BRAIN BARRIER DAMAGE
NAD+ associated_with Cellular Processes
NAD+ modulates inflammation

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.